Dreussi, E.; Cecchin, E.; Polesel, J.; Canzonieri, V.; Agostini, M.; Boso, C.; Belluco, C.; Buonadonna, A.; Lonardi, S.; Bergamo, F.;
et al. Pharmacogenetics Biomarkers and Their Specific Role in Neoadjuvant Chemoradiotherapy Treatments: An Exploratory Study on Rectal Cancer Patients. Int. J. Mol. Sci. 2016, 17, 1482.
https://doi.org/10.3390/ijms17091482
AMA Style
Dreussi E, Cecchin E, Polesel J, Canzonieri V, Agostini M, Boso C, Belluco C, Buonadonna A, Lonardi S, Bergamo F,
et al. Pharmacogenetics Biomarkers and Their Specific Role in Neoadjuvant Chemoradiotherapy Treatments: An Exploratory Study on Rectal Cancer Patients. International Journal of Molecular Sciences. 2016; 17(9):1482.
https://doi.org/10.3390/ijms17091482
Chicago/Turabian Style
Dreussi, Eva, Erika Cecchin, Jerry Polesel, Vincenzo Canzonieri, Marco Agostini, Caterina Boso, Claudio Belluco, Angela Buonadonna, Sara Lonardi, Francesca Bergamo,
and et al. 2016. "Pharmacogenetics Biomarkers and Their Specific Role in Neoadjuvant Chemoradiotherapy Treatments: An Exploratory Study on Rectal Cancer Patients" International Journal of Molecular Sciences 17, no. 9: 1482.
https://doi.org/10.3390/ijms17091482
APA Style
Dreussi, E., Cecchin, E., Polesel, J., Canzonieri, V., Agostini, M., Boso, C., Belluco, C., Buonadonna, A., Lonardi, S., Bergamo, F., Gagno, S., De Mattia, E., Pucciarelli, S., De Paoli, A., & Toffoli, G.
(2016). Pharmacogenetics Biomarkers and Their Specific Role in Neoadjuvant Chemoradiotherapy Treatments: An Exploratory Study on Rectal Cancer Patients. International Journal of Molecular Sciences, 17(9), 1482.
https://doi.org/10.3390/ijms17091482
